Attending this year’s American Association of Cancer Research (AACR) Meeting in New Orleans, Drug Target Review’s Editor Victoria Rees heard from Dr Margaret Foti, CEO of the AACR, at the Opening Ceremony.
“Despite the challenges, this is an incredibly exciting, innovative and hopeful time in cancer research,” Foti highlighted. “As reflected in the theme of this year’s meeting, decoding cancer complexity, integrating science, transforming patient outcomes – the pioneering strides you and your colleagues are making across the spectrum of cancer science are driving transformative progress against the disease at an exhilarating pace.”
Comments